The goal of this study was to determine the relations between the risk of colorectal neoplasia and obesity markers: body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR).
INTRODUCTION
There is a trend of increasing obese population from the intro- , which is very close to the 34.9% prevalence of obesity among American adults. 3 It is a widely known fact that obesity can cause metabolic disorders, such as hypertension, diabetes, and dyslipidemia 4 , and by causing such diseases, obesity is directly responsible for increasing the prevalence of various diseases and mortality rate. 5 Recently, a number of studies have reported that obesity is a risk factor for various malignancies, placing greater emphasis on obesity. Among them, colorectal cancer accounts for 10 .0% of all cancer cases and represents the 4th and 3rd most common cancer among men and women, respectively, worldwide. 6 In most colorectal cancer cases, adenomatous colorectal polyps and precancerous lesions progress by an adenoma-carcinoma sequence.
Several lifestyle factors are associated with the adenoma-carcinoma sequence. High fat diet, smoking, excessive alcohol consumption, physical activity, obesity and insulin resistance are known to be associated. 7 Colorectal cancer has the 3rd highest prevalence among all cancers in Korea, following only thyroid and gastric cancer; in 5.6%, which is believed to be closely associated with the rapid increase in the prevalence of obesity caused primarily by a decrease in physical activities and Westernized dietary habits from recent socioeconomic advances in Korea. 8, 9 The cost burden associated with the increase in colorectal cancer population is also expected to increase exponentially; thus, in cases where metabolic syndrome is a preventable risk factor for colorectal neoplasia, socioeconomic benefits can be expected from the decrease in the incidence of colorectal cancer by managing obesity through exercise and weight loss strategies. However, although many studies have examined the relationship between obesity and colorectal cancer, very few have examined the relationship between obesity and colorectal neoplasia, such as colorectal polyps, with such studies lacking especially in Korea.
Accordingly, the present study investigated the association of the occurrence of colorectal neoplasia with obesity in average-risk Korean adults. Moreover, the study used these obesity markers in determining whether such markers can effectively predict the risk for colorectal neoplasia.
METHODS

Subjects
The present study conducted a retrospective chart review of Korean adults (20 years 
Methods
Demographic characteristics
The information the patients had filled out personally in the questionnaire was retrospectively reviewed to determine their personal and family medical history and smoking, drinking, and exer- 
Blood tests
As laboratory findings, total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL)
cholesterol, blood glucose, glycated hemoglobin, and carcinoembryonic antigen (CEA) levels from blood tests performed on an empty stomach after ≥ 8 hours of fasting were investigated.
Colonoscopy
In preparing for the colonoscopy, 4 L of Colyte-F was used as the colon cleanser to empty the bowel. Afterwards, while maintaining an empty stomach, the procedure was performed by a gastrointestinologist with an experience of performing more than 1,000 cases of colonoscopy. Biopsy was performed in all cases that showed any abnormal findings during colonoscopy, and the cases were classified on the basis of the pathological biopsy results as no adenoma, nonspecific finding, tubular adenoma, advanced adenoma, and cancer depending on how advanced the malignancy was. Hyperplastic polyp and chronic colitis were classified as nonspecific findings. In cases where several lesions were found at once on the same subject, the classification was made on the basis of the most advance pathological result. The subjects were assigned to the neoplasia group if they had tubular adenoma, advanced adenoma, or colorectal cancer and the control group if they had no adenoma or only nonspecific findings.
Statistical analyses
The analyses were performed with the subjects divided into the neoplasia and control groups according to the criteria pre- For all statistical results, P value < 0.05 was considered statistically significant.
RESULTS
Comparisons of subject characteristics and obesity markers
Among the total of 286 patients who had undergone a colonoscopy during the study period, 18 were excluded based on the exclusion criteria, leaving 268 patients as the subjects of the final analy- there was also no statistically significant difference between the two groups. WHtR was also higher in the neoplasia group than in the control group (0.51 vs 0.49, P= 0.001), and when the obesity criterion of 0.5 was applied, 69.9% of the neoplasia group and 48.6% of the control group were identified as obese, with the difference being statistically significant (P= 0.001).
As compared to the control group, the neoplasia group showed a significantly higher systolic blood pressure (126.1 vs 120.3, P = 0.006), diastolic blood pressure (77.7 vs 74.6, P = 0.017), triglyceride levels (177.5 vs 134.0, P = 0.017), and prevalence of hypertension (38.6% vs 26.5%, P = 0.047), while showing lower HDL cholesterol levels (50.5 vs 57.2, P < 0.001). There were no statistically significant differences between the two groups with respect to other physical examinations and blood test results, diabetes and dyslipidemia status, and lifestyle factors (Table 1) .
Correlations between colorectal neoplasia and obesity markers
The logistic regression analysis was performed with the presence of colorectal neoplasia, as the dependent variable and each obesity marker as independent variables, which were adjusted for metabolic factors known to be associated with obesity, such as sex, age, diabetes, hypertension, and exercise, smoking, and drinking status. When all of the subjects were analyzed, there was no significant correlation between colorectal neoplasia and obesity classified by the criteria of BMI and WC, whereas in cases of obesity with WHtR ≥ 0.5, a significant association was found with the odds ratio of having colorectal neoplasia being 1.927 (95% CI, 1.041-3.569).
All factors mentioned above, except sex, were adjusted in performing separate analyses for men and women. The results indicat- . In men, no significant association was also found between the presence of colorectal neoplasia and any of the obesity markers ( Table 2) .
Analysis of the cut-off points of the obesity markers for predicting colorectal neoplasia
An ROC curve analysis was performed to determine whether each obesity marker would be effective in predicting colorectal neoplasia, including tubular adenoma, advanced adenoma, and cancer and their corresponding appropriate cut-off points. When BMI was > 23.14 kg/m 2 , best sensitivity (75.90%) and specificity (48.65%) for predicting colorectal neoplasia were seen, which were statistically significant (AUC = 0.610, P= 0.002). WC was analyzed separately for men and women; for men, the cut-off point was WC > 82.5 cm, which showed no statistical significance (AUC = 0.521, P = 0.650). Meanwhile, the cut-off point for women was WC > 77 cm (sensitivity 78.95% and specificity 65.12%), which showed a statistical significance with a moderately accurate AUC of 0.731 (P< 0.001). The adequate cut-off point for WHtR was found to be WHtR > 0.50, which was also statistically significant (AUC = 0.626, P< 0.001) (Fig. 1) .
DISCUSSION
The present study was a cross-sectional study that aimed to examine the associations between colorectal neoplasia and obesity. The study found that obesity was significantly associated with colorectal neoplasia, including tubular adenoma, advanced adenoma, or cancer. Among the obesity markers, WHtR was a better indicator of colorectal neoplasia than BMI or WC; among women, WC was also found to be a useful marker.
The 5-year survival rate for colorectal cancer may vary significantly depending on how advanced the lesion is at the time of diagnosis 13 ; as such, there have been continued efforts to identify its risk factors for prevention and early diagnosis. Studies have found that approximately 75% of colorectal cancer cases are caused by modifiable environmental factors, such as obesity, red or processed meat consumption, reduced physical activities, and drinking.
14 Among these risk factors, obesity is considered as the most important risk factor. Obesity increases the risk of colorectal neoplasia, such as adenoma and colorectal cancer, by being involved with endotoxemia, metabolic syndrome, and chronic low grade inflammation associated with insulin, insulin-like growth factors, adipokines, cytokines, and chemokines. [15] [16] [17] According to actual epidemiological study reports, a study on Japanese subjects showed that when a BMI of 25 kg/m 2 was applied, which is the same criterion used in Korea, the risk for colorectal cancer increased by 1.5 fold in the obese population compared to those with normal weight. 18 Moreover, a meta-analysis conducted mostly on Westerners showed that as BMI increased each time by 5 kg/m 2 , the risk for colorectal cancer also increased by 1.13 and 1.06 folds in men and women, respectively. Furthermore, obesity also increased the risk for adenoma and precancerous colorectal lesions in a similar manner as in colorectal cancer, with an increase of 5 kg/m 2 in BMI, resulting in increased risks for colorectal adenoma by 1.19-3.83 folds [19] [20] [21] [22] [23] , which is indicative of how important the association between obesity and colorectal neoplasia is.
The results in the present study showed that patients with colorectal neoplasia had higher BMI, WC, and WHtR, which supported the findings of previous studies. However, when the association between obesity and colorectal neoplasia was examined with obesity classified according to the known criteria of BMI, WC, and
WHtR and all known risk factors for colorectal cancer being adjusted, there was no statistically significant association between the risk for neoplasia and obesity based on BMI. According to a previous meta-analysis, an increase in BMI, WC, and WHtR tended to increase the risk for colorectal cancer 24 ; however, because different studies used different obesity markers, the results were not always consistent. As a result, which marker is most appropriate is still controversial. Although BMI is the most commonly used marker to measure the degree of obesity, the marker that has a direct influence on the onset of colorectal neoplasia from a physiological perspective is considered to be abdominal obesity. This is because abdominal visceral fat has a high physiological activity level and is easily dissolved; as a result, a high level of free fatty acids is released to interfere with the insulin signaling process, which causes an insulin resistance. 15 Consequently, WC or WHtR, which reflects abdominal obesity better than BMI does, are expected to be more effective in predicting the risk for colorectal neoplasia; further, previous studies conducted in Japan and Korea 25, 26 also showed that obesity markers that reflect abdominal obesity, such as waist-to-hip ratio, were more useful in predicting adenomatous polyps than BMI, which supported the finding in the present study.
Another interesting point in the present study was that men did not show statistical significance with respect to BMI, WC, and WHtR, whereas women showed significant associations with obesity of WC ≥ 85 cm showing a 4.6 fold increase in the risk for colorectal neoplasia and obesity of WHtR ≥ 0.5 also showing a 4.7
fold increase. These findings were slightly different than the results of previous studies that showed stronger associations in men 20, 23 , which may be attributed to the following factors: First, the present study adjusted for all possible factors, unlike previous studies. Second, the present study examined only Koreans; thus, the results may vary from other studies that included many Caucasians. Since Asians tend to show higher risks for colorectal cancer than other races according to BMI increase 27 , racial differences cannot be disregarded. A study on Japanese subjects also showed that the association between WHtR and colorectal cancer was more significant in women than in men 28 , which was similar to the finding in the present study and also serves as an evidence that a racial difference exists. Third, compared to previous studies that used the obesity criteria for Westerners, the present study used more stringent criteria for obesity, which may have led to different results being obtained.
In addition, the subjects in the present study were relatively younger than those in previous studies, and others factors, such as female hormones, diet, differences in pathological stages, and genetic modifications 29 can also be considered with respect to the possibility of different results being found. 30 In the present study, the ROC curve analysis was used to find the cut-off points of the obesity markers for predicting the onset of colorectal neoplasia. The cut-off point for BMI and WHtR was found to be 23.14 kg/m 2 and 0.50, respectively, while WC for women was 77 cm. AUC of each was found to be statistically significant. Among these, WHtR showed the highest AUC value among both men and women, while WC showed the highest value among women only; this suggests that in order to predict high risk groups for colorectal neoplasia, the focus should be on abdominal obesity rather than BMI. The cut-off point of WHtR for the most effective prediction of actual risks for cardiovascular diseases was 0.50, and
WHtR better reflected the risk for cardiovascular diseases than WC or BMI, which supports the findings in the present study. 31, 32 The present study has the following limitations: First, because the study investigated patients who had visited a single university hospital on their own, it is possible that the study was biased towards those who would normally be interested in their health, which means that this population may not represent the entire community. Second, because all information related to drinking, smoking, and exercise were based on the questionnaire given by the examiner, it is possible that recall-bias may have been involved.
Third, other confounding factors that can influence the onset of colorectal neoplasia, such as dietary habits, level of physical activity among activities of daily living, menopausal status, and location and size of colorectal neoplasia were not excluded. Fourth, the study did not perform serological tests on sex hormones and adipocytokines nor evaluate insulin resistance, which has been suggested as a major pathogenic factor.
Despite those limitations, the present study has certain strengths.
We identified possible confounding variables, such as smoking, drinking, and exercise through an objective questionnaire survey and adjusting for those variables. Moreover, it was the first study in
Korea to compare the adequacy of risk factors for colorectal cancer by conducting an ROC curve analysis on obesity markers and analyzing the association between obesity and colorectal neoplasia, including colorectal adenoma and colorectal cancer.
In conclusion, obesity is associated with increased risks for colorectal neoplasia; in particular, WHtR measurement is relatively simple and highly accurate, which can be considered as a meaningful test in screening for high risk groups for colorectal neoplasia. It would be necessary to conduct large-scale prospective studies using a greater variety of obesity markers and to examine whether the treatment of obesity through lifestyle adjustments and drug treatments can lead to a decreased incidence of colorectal neoplasia.
